Injective (INJ) is currently priced at $4.18, reflecting a 1% decline over the past 24 hours. The daily trading range has been relatively tight, with a high of $4.27 and a low of $4.12, indicating low volatility in the short term.

Volume stands at 42,583,065, translating to a volume-to-market cap ratio of 10.19%, suggesting decent trading activity relative to its market capitalization. The short-term moving averages indicate a slight bearish sentiment, particularly with the 55 SMA at $4.35 showing a decline of 3.86%, while the longer-term 144 SMA at $4.46 reflects a more significant drop of 6.19%.

The 1-hour RSI is at 49, signaling neutrality, while the 7-day RSI is slightly lower at 48, suggesting that the asset is neither overbought nor oversold. Price changes over various time frames illustrate a bearish trend, with a 7-day change of -5.3%, a 14-day change of -15%, and a 30-day change of -15.5%.

The all-time high for INJ stands at $52.62, reached on March 14, 2024, indicating significant room for recovery but also emphasizing the current distance from its peak. With ongoing price declines and lack of bullish momentum in both short and medium-term indicators, market sentiment appears cautious.

Given the current bearish indicators and the lack of significant price recovery signals, a Sell rating is appropriate for Injective (INJ) at this time. Continued downward pressure in the price and negative RSI trends suggest that traders should consider exiting their positions until clearer bullish signals emerge.